United Therapeutics Corp (UTHR)
236.04
+1.88
(+0.80%)
USD |
NASDAQ |
Apr 23, 13:18
United Therapeutics Cash from Operations (TTM): 978.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 978.00M |
| September 30, 2023 | 955.50M |
| June 30, 2023 | 867.90M |
| March 31, 2023 | 888.60M |
| December 31, 2022 | 802.50M |
| September 30, 2022 | 848.90M |
| June 30, 2022 | 775.90M |
| March 31, 2022 | 797.10M |
| December 31, 2021 | 598.20M |
| September 30, 2021 | 549.80M |
| June 30, 2021 | 615.10M |
| March 31, 2021 | 630.90M |
| December 31, 2020 | 755.70M |
| September 30, 2020 | 732.00M |
| June 30, 2020 | 666.50M |
| March 31, 2020 | 635.40M |
| December 31, 2019 | -206.60M |
| September 30, 2019 | -223.70M |
| June 30, 2019 | -171.60M |
| March 31, 2019 | -124.70M |
| December 31, 2018 | 778.40M |
| September 30, 2018 | 607.20M |
| June 30, 2018 | 628.20M |
| March 31, 2018 | 519.10M |
| December 31, 2017 | 474.20M |
| Date | Value |
|---|---|
| September 30, 2017 | 723.40M |
| June 30, 2017 | 693.60M |
| March 31, 2017 | 748.60M |
| December 31, 2016 | 643.60M |
| September 30, 2016 | 505.70M |
| June 30, 2016 | 484.20M |
| March 31, 2016 | 399.50M |
| December 31, 2015 | 382.80M |
| September 30, 2015 | 447.95M |
| June 30, 2015 | 449.28M |
| March 31, 2015 | 353.80M |
| December 31, 2014 | 355.30M |
| September 30, 2014 | 369.08M |
| June 30, 2014 | 299.84M |
| March 31, 2014 | 438.17M |
| December 31, 2013 | 425.27M |
| September 30, 2013 | 426.06M |
| June 30, 2013 | 380.20M |
| March 31, 2013 | 383.74M |
| December 31, 2012 | 323.63M |
| September 30, 2012 | 270.05M |
| June 30, 2012 | 257.28M |
| March 31, 2012 | 234.43M |
| December 31, 2011 | 250.20M |
| September 30, 2011 | 237.82M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-223.70M
Minimum
Sep 2019
978.00M
Maximum
Dec 2023
605.06M
Average
732.00M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| Liquidia Corp | -41.56M |
| Esperion Therapeutics Inc | -135.49M |
| Vertex Pharmaceuticals Inc | 3.537B |
| Heron Therapeutics Inc | -58.79M |
| Aldeyra Therapeutics Inc | -30.33M |